AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 APR 11 - (NewsRx.com & NewsRx.net) --
by N.R. Saltmarsh, staff medical writer - Large-scale vaccination of healthy working adults would generate cost savings in most situations, according to a new study in the Archives of Internal Medicine.
Because most people 18 to 64 years old are not currently vaccinated against influenza, this may represent a good population to target, noted K.L. Nichol, of the Veterans Affairs Medical Center in Minneapolis, Minnesota.
Nichol used data from published literature to analyze the direct and indirect costs and benefits of vaccination in this age group, assuming the use of efficient and low-cost practices.
Using Monte Carlo simulation, Nichol calculated that vaccinating healthy working adults was cost-effective 95% of the time, and saved an average of $13.66 per vaccinated person in terms of lost work days and other, indirect costs ("Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza," Arch Intern Med, March 2001;161(5):749-759).
In years with low vaccine effectiveness, vaccination would not be cost-effective, but in all other ...